St Jude Medical Inc (STJ)

80.82
0.13 0.16
NYSE : Health Care
Prev Close 80.69
Open 80.80
Day Low/High 80.72 / 81.31
52 Wk Low/High 48.83 / 84.00
Volume 14.74M
Avg Volume 2.67M
Exchange NYSE
Shares Outstanding 285.72M
Market Cap 23.09B
EPS 3.10
P/E Ratio 35.39
Div & Yield 1.24 (1.50%)

Latest News

Weekly Roundup

After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.

Abbott Labs: Diagnosing Growth in 2017

Abbott Labs: Diagnosing Growth in 2017

ABT could be on course for 10% earnings growth this year, but will investors reward the company with a higher share price?

Abbott Laboratories Can Merge With St. Jude Medical: FTC

Abbott Laboratories Can Merge With St. Jude Medical: FTC

The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical

Abbott can now proceed with its $25 billion buy of St. Jude Medical.

Carson Block's Muddy Waters Churns China Huishan Dairy With Claim of 'Zero Value'

Carson Block's Muddy Waters Churns China Huishan Dairy With Claim of 'Zero Value'

Shares in China's biggest dairy company are suspended after the notorious short-seller alleges accounting fraud, illegal payments and crippling debt.

St. Jude Medical Announces Fourth Quarter Dividend

St. Jude Medical Announces Fourth Quarter Dividend

St. Jude Medical, Inc.

Proclaim™ Elite Spinal Cord Stimulation System (Photo: Business Wire)

Proclaim™ Elite Spinal Cord Stimulation System (Photo: Business Wire)

St. Jude Medical, Inc.

Abbott Looks to Kill Alere Deal

Abbott Looks to Kill Alere Deal

The medical device giant files a suit against Alere in the Delaware Court of Chancery hoping to walk away from their $7.9 billion merger agreement.

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

HeartMate 3 Left-ventricular Assist System (Photo: Business Wire)

HeartMate 3 Left-ventricular Assist System (Photo: Business Wire)

St. Jude Medical, Inc.

European Union Regulators Said to Approve Abbott's St. Jude Acquisition

European Union Regulators Said to Approve Abbott's St. Jude Acquisition

European Union regulators are expected to approve Abbott Laboratories' $33 billion acquisition of St. Jude Medical.

Quadra Allure MP CRT-P (Photo: Business Wire)

Quadra Allure MP CRT-P (Photo: Business Wire)

St. Jude Medical, Inc.

The Internet of Things Is Transforming Healthcare, but There's One Huge Risk

The Internet of Things Is Transforming Healthcare, but There's One Huge Risk

Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.

St. Jude Medical Shareholders Approve Merger With Abbott

St. Jude Medical Shareholders Approve Merger With Abbott

St. Jude Medical, Inc.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

St. Jude Medical Still a Buy Despite Product Concerns

St. Jude Medical Still a Buy Despite Product Concerns

St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Miles White also reiterated that Abbott Laboratories has no plans to divest of its diabetes business. He still believes in Alere over the long term.

St. Jude Spars With Muddy Waters After Earnings Miss

St. Jude Spars With Muddy Waters After Earnings Miss

The medical device maker responded to allegations that its devices could be hacked during its third quarter earnings call.